Cyclolinopeptide A: Inhibitor, immunosuppressor or other?

Journal of Peptide Science

Volumn 11, Issue 5, 2005, Pages 268-272

  Benedetti, Ettore ^a   Pedone, Carlo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bioactive peptides; Conformation; Crystal structure; Cyclic peptides; NMR; Peptide analogues

Indexed keywords

ACETONE; ANTAMANIDE; CALCINEURIN; CYCLOLINOPEPTIDE A; CYCLOPHILIN; CYCLOSPORIN A; FK 506 BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 2; LINSEED OIL; PHALLOTOXIN; TACROLIMUS;

ARTICLE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; DRUG ISOLATION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; GAS CHROMATOGRAPHY; IMMUNE RESPONSE; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN CONFORMATION; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; T LYMPHOCYTE ACTIVATION; THREE DIMENSIONAL IMAGING;

AMINO ACID SEQUENCE; HISTORY, 20TH CENTURY; IMMUNOSUPPRESSIVE AGENTS; MODELS, MOLECULAR; PEPTIDES, CYCLIC; PROTEIN CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 18844368590     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.674     Document Type: Article

References (31)

1. Kaufmann HP, Tobschirbel A. An oligopeptide from linseed. Chem. Ber. 1959; 92: 2805-2809.
2. Prox A, Weygand F. Sequenzanalyse von peptiden durch kombination von gaschromatographie und massenspektrometrie. In Peptides. Proc. 8th Eur. Peptide Symp., Beyerman HC, van de Linde A, Maasen van den Brink W (eds). North-Holland: Amsterdam, 1967; 158-172.
3. Naider F, Benedetti E, Goodman M. Conformation of cyclolinopeptide A observed by circular dichroism. Proc. Natl Acad. Sci. USA 1971; 68: 1195-1198.
4. Brewster AI, Bovey FA. Conformation of cyclolinopeptide A observed by nuclear magnetic resonance spectroscopy. Proc. Natl Acad. Sci. USA 1971; 68: 1199-1202.
5. Tonelli AE. Approximate treatment of the conformational characteristics of a cyclic nonapeptide, cyclolinopeptide A. Proc. Natl Acad. Sci. USA 1971; 68: 1203-1207.
6. Wieland T, Luben G, Ottenheim H, Faesel J, de Vries JX, Konz W, Prox A, Schmid J. Chemical composition of Amanita phalloides. XXXVI. Discovery, isolation, elucidation of structure, and synthesis of antamanide. Angew. Chem. Int. Ed. Engl. 1968; 7: 204-208.
7. Wieland T. Peptides of Poisonous Amanita Mushrooms, Rich A (ed). Springer Verlag: Berlin, 1986.
8. Raptis S, Rosenthal J, Gerich E (eds). Proc. 2nd Int. Symp. Somatostatin. Attempto Verlag: Tubingen, 1984.
9. Wieland T, Nassal M, Kramer W, Fricker G, Bichel U, Kurz G. Identity of hepatic membrane transport systems for bile salts, phalloidin, and antamanide by photoaffinity labeling. Proc. Natl Acad. Sci. USA 1984; 81: 5232-5236.
10. Ziegler K, Frimmer H, Kessler H, Haupt A. Azidobenzamido-008, a new photosensitive substrate for the 'multispecific bile acid transporter' of hepatocytes: evidence for a common transport system for bile acids and cyclosomatostatins in basolateral membranes. Biochim. Biophys. Acta 1988; 945: 263-272.
11. Kemmer H, Tripier D, Jouvenal K, Scriba D, Zanotti G, Maione AM, Ziegler K. Binding proteins for cyclic and linear oligopeptides in plasma membranes and the cytosol of rat hepatocytes. Biochem. Pharmacol. 1997; 54: 481-490.
12. Wieczorek Z, Siemion IZ, Zimecki M, Bolewska-Pediczak E, Wieland T. Immunosuppressive activity in the series of cycloamanide peptides from mushrooms. Peptides 1993; 14: 1-5.
13. Wieczorek Z, Bengtsson B, Trojnar J, Siemion IZ. Immunosuppressive activity of cyclolinopeptide A. Pept. Res. 1991; 4: 275-283.
14. Gallo P, Saviano M, Rossi F, Pavone V, Pedone C, Ragone R, Stiuso P, Colonna G. Specific interaction between cyclophilin and cyclic peptides. Biopolymers 1995; 36: 273-281.
15. Karle IL. Lithium perhydroantamanide complex (2: 1): exposure of the peptide backbone in the analog of antamanide with antitoxic impotency. Proc. Natl Acad. Sci. USA 1985; 82: 7155-7159.
16. Di Blasio B, Rossi F, Benedetti E, Pavone V, Pedone C, Temussi PA, Zanotti G, Tancredi T. Bioactive peptides: solid-state and solution conformation of cyclolinopeptide A. J. Am. Chem. Soc. 1989; 111: 9089-9098.
17. Kessler H, Bats JW, Giesinger C, Koll S, Wiel M, Wagner K. Peptide conformations. 46. Conformational analysis of a superpotent cytoprotective cyclic somatostatin analog. J. Am. Chem. Soc. 1988; 110: 1033-1049.
18. Di Blasio B, Benedetti E, Pavone V, Pedone C, Goodman M. Conformations of bioactive peptides: cyclolinopeptide A. Biopolymers 1987; 26: 2099-2101.
19. Neela BS, Manjula MV, Ramakumar S, Vismamitra MA. Crystal structure of the triclinic form of cyclolinopeptide A. XVth IUCr, Bordeaux, France, 1990; MS-04.01.09.
20. Karle IL, Wieland T, Schermer D, Ottenheym HCJ. Conformation of uncomplexed natural antamanide crystallized from acetonitrile/water. Proc. Natl Acad. Sci. USA 1979; 76: 1532-1536.
21. Di Blasio B, Rossi F, Benedetti E, Pavone V, Saviano M, Pedone C, Zanotti G, Tancredi T. Bioactive peptides: X-ray and NMR conformational study of [Aib5,6-D-Ala8]cyclolinopeptide A. J. Am. Chem. Soc. 1992; 114: 8277-8283.
22. Zanotti G, Maione A, Rossi F, Saviano M, Pedone C, Tancredi T. Bioactive peptides: conformational study of a cystinyl cycloheptapeptide in its free and calcium complexed forms. Biopolymers 1993; 33: 1083-1091.
23. Zanotti G, Rossi F, Di Blasio B, Pedone C, Benedetti E, Ziegler K, Tancredi T. Structure-activity relationship in cytoprotective peptides. In Peptides. Chemistry, Structure and Biology, Rivier J, Marshall GR (eds). ESCOM: Leiden, 1990; 118-119.
24. Morelli M, Castiglione A, Pastore A, Pedone C, Temussi PA, Zanotti G, Tancredi T. Conformational study of cyclolinopeptide A. A distance geometry and molecular dynamics approach. Int. J. Pept. Protein Res. 1991; 37: 81-89.
25. Veber DF, Holly FW, Paleveda WJ, Nutt RF, Bergstrand SJ, Torchiana M, Glitzer MS, Saperstein R, Hirschmann R. Conformationally restricted bicyclic analogs of somatostatin. Proc. Natl Acad. Sci. USA 1978; 75: 2636-2640.
26. Mierke DF, Pattaroni C, Delaet N, Toy A, Goodman M, Tancredi T, Motta A, Temussi PA, Moroder L, Bovermann G, Wünsch E. Cyclic hexapeptides related to somatostatin. Conformational analysis employing 1H-NMR and molecular dynamics. Int. J. Pept. Protein Res. 1990; 36: 418-432.
27. Sawyer TK, Cody WL, Knittel JJ, Hruby VJ, Hadley ME, Hirsch MD, O'Donohue TL. Design of conformationally-restricted cyclic XX-melanotropins: comparison of melanocyte-stimulating and behavioral activities. In Peptides, Structure and Function, Hruby VJ, Rich DH (eds). Pierce Chemical Company: Rockford, IL, 1983; 323-331.
28. Schiller PW, Nguyen TMD, Maziak L, Lemieux C. A novel cyclic opioid peptide analog showing high preference for μ-receptors. Biochem. Biophys. Res. Commun. 1985; 127: 558-564.
29. Lautz J, Kessler H, Boelens R, Kaptein R. Conformational analysis of a cyclic thymopoietin analog by proton NMR spectroscopy and restrained molecular dynamics simulations. Int. J. Pept. Protein Res. 1987; 30: 404-414.
30. Heavner GA, Audhya T, Doyle D, Tjoeng F, Goldstein G. Biologically active conformations of thymopentin. Studies with conformationally restricted analogs. Int. J. Pept. Protein Res. 1991; 37: 198-209.
31. Zanotti G, Tancredi T, Rossi F, Benedetti E, Pedone C. Ala analogues of the cyclolinopeptide. Biopolymers 1989; 28: 371-383.